Similar articles for PMID: 2036681

Year	Number of Results
1984	1
1986	1
1988	1
1989	4
1990	4
1991	12
1992	9
1993	19
1994	11
1995	8
1996	3
1997	11
1998	4
1999	4
2001	4
2002	2
2003	1
2006	2
2007	1
2008	2
2009	1
2013	2
2014	1
2015	2
2019	3
2024	0

1

Increased tumor-specific CTL activity in human tumor-infiltrating lymphocytes stimulated with autologous tumor lines.

Reilly EB, Antognetti G. Reilly EB, et al. Cell Immunol. 1991 Jul;135(2):526-33. doi: 10.1016/0008-8749(91)90295-m. Cell Immunol. 1991. PMID: 2036681

2

Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines.

Schendel DJ, Gansbacher B, Oberneder R, Kriegmair M, Hofstetter A, Riethmüller G, Segurado OG. Schendel DJ, et al. J Immunol. 1993 Oct 15;151(8):4209-20. J Immunol. 1993. PMID: 8409397

3

T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.

Sensi M, Salvi S, Castelli C, Maccalli C, Mazzocchi A, Mortarini R, Nicolini G, Herlyn M, Parmiani G, Anichini A. Sensi M, et al. J Exp Med. 1993 Oct 1;178(4):1231-46. doi: 10.1084/jem.178.4.1231. J Exp Med. 1993. PMID: 8376931 Free PMC article.

4

Shared human melanoma antigens. Recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomas.

Kawakami Y, Zakut R, Topalian SL, Stötter H, Rosenberg SA. Kawakami Y, et al. J Immunol. 1992 Jan 15;148(2):638-43. J Immunol. 1992. PMID: 1729379

5

Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.

Itoh K, Platsoucas CD, Balch CM. Itoh K, et al. J Exp Med. 1988 Oct 1;168(4):1419-41. doi: 10.1084/jem.168.4.1419. J Exp Med. 1988. PMID: 3262710 Free PMC article.

6

Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.

Baxevanis CN, Dedoussis GV, Papadopoulos NG, Missitzis I, Stathopoulos GP, Papamichail M. Baxevanis CN, et al. Cancer. 1994 Aug 15;74(4):1275-82. doi: 10.1002/1097-0142(19940815)74:4<1275::aid-cncr2820740416>3.0.co;2-q. Cancer. 1994. PMID: 7914469

7

Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition.

Stevens EJ, Jacknin L, Robbins PF, Kawakami Y, el Gamil M, Rosenberg SA, Yannelli JR. Stevens EJ, et al. J Immunol. 1995 Jan 15;154(2):762-71. J Immunol. 1995. PMID: 7814882

8

Recognition of shared melanoma antigen by HLA-A2-restricted cytolytic T cell clones derived from human tumor-infiltrating lymphocytes.

Viret C, Davodeau F, Guilloux Y, Bignon JD, Semana G, Breathnach R, Jotereau F. Viret C, et al. Eur J Immunol. 1993 Jan;23(1):141-6. doi: 10.1002/eji.1830230123. Eur J Immunol. 1993. PMID: 8419164

9

Common expression of melanoma tumor-associated antigens recognized by human tumor infiltrating lymphocytes: analysis by human lymphocyte antigen restriction.

Hom SS, Topalian SL, Simonis T, Mancini M, Rosenberg SA. Hom SS, et al. J Immunother (1991). 1991 Jun;10(3):153-64. J Immunother (1991). 1991. PMID: 1868040

10

The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens.

Darrow TL, Slingluff CL Jr, Seigler HF. Darrow TL, et al. J Immunol. 1989 May 1;142(9):3329-35. J Immunol. 1989. PMID: 2785141

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

111 results

Results by year